Prophylaxis of migraine headache
- PMID: 20159899
- PMCID: PMC2855933
- DOI: 10.1503/cmaj.081657
Prophylaxis of migraine headache
Comment in
-
ACP Journal Club. Review: Some drugs are effective for preventing migraine headache; limited evidence exists on the relative effectiveness of drugs.Ann Intern Med. 2010 Nov 16;153(10):JC5-4. doi: 10.7326/0003-4819-153-10-201011160-02004. Ann Intern Med. 2010. PMID: 21079211 No abstract available.
Similar articles
-
Pharmacological prevention of migraine.BMJ. 2011 Feb 18;342:d583. doi: 10.1136/bmj.d583. BMJ. 2011. PMID: 21335409 Review. No abstract available.
-
Botulinum toxin for chronic migraine.Med Lett Drugs Ther. 2011 Jan 24;53(1356):7-8. Med Lett Drugs Ther. 2011. PMID: 21252842 No abstract available.
-
OnabotulinumtoxinA for treatment of chronic migraine: the unblinding problem.Headache. 2013 May;53(5):824-6. doi: 10.1111/head.12065. Epub 2013 Mar 6. Headache. 2013. PMID: 23465058 No abstract available.
-
Onabotulinumtoxin [corrected] A (Botox).Headache. 2014 Apr;54(4):787-8. doi: 10.1111/head.12342. Headache. 2014. PMID: 24697235 Review. No abstract available.
-
Botulinum toxin type A for the treatment of migraine.Expert Opin Pharmacother. 2006 Jun;7(8):1085-95. doi: 10.1517/14656566.7.8.1085. Expert Opin Pharmacother. 2006. PMID: 16722818 Review.
Cited by
-
Migraine prophylaxis: what is new and what we need?Neurol Sci. 2011 May;32 Suppl 1:S111-5. doi: 10.1007/s10072-011-0526-3. Neurol Sci. 2011. PMID: 21533725 Review.
-
A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine.Neurol Sci. 2014 Mar;35(3):429-35. doi: 10.1007/s10072-013-1536-0. Epub 2013 Sep 13. Neurol Sci. 2014. PMID: 24030685 Clinical Trial.
-
The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic.Headache. 2020 Oct;60(9):2085-2086. doi: 10.1111/head.13945. Headache. 2020. PMID: 32790208 Free PMC article. No abstract available.
-
Capsule Commentary on Jackson et al., Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis.J Gen Intern Med. 2017 Dec;32(12):1350. doi: 10.1007/s11606-017-4133-8. J Gen Intern Med. 2017. PMID: 28730533 Free PMC article. No abstract available.
-
Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.Curr Pain Headache Rep. 2019 Sep 12;23(11):85. doi: 10.1007/s11916-019-0823-8. Curr Pain Headache Rep. 2019. PMID: 31515634
References
-
- International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia. 2004;24(Suppl 1):1–160. - PubMed
-
- Silberstein SD the United States Headache Consortium. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) Neurology. 2000;55:754–62. - PubMed
-
- Members of the European Federation of Neurological Societies task force. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine — report of an EFNS task force. Eur J Neurol. 2006;13:560–72. - PubMed
-
- Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology. 2006;66:1894–8. - PubMed
-
- Jelinski SE, Becker WJ, Christie SN, et al. Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada. Cephalalgia. 2006;26:578–88. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical